• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺的药代动力学磁共振成像:区分低级别和高级别前列腺癌的参数]

[Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].

作者信息

Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D

机构信息

Institut für Radiologie CCM, Charité - Universitätsmedizin Berlin.

出版信息

Rofo. 2009 Jun;181(6):536-42. doi: 10.1055/s-0028-1109168. Epub 2009 Apr 7.

DOI:10.1055/s-0028-1109168
PMID:19353483
Abstract

PURPOSE

To investigate whether pharmacokinetic MRI parameters "perfusion, blood volume, mean transit time (MTT), interstitial volume, permeability, extraction coefficient, delay, and dispersion" allow the differentiation of low-grade (Gleason score < or = 6) and high-grade (Gleason score > or = 7) prostate cancer.

MATERIALS AND METHOD

Forty-two patients with prostate cancer verified by biopsy (PSA 2.7 to 31.4 ng/ml) and scheduled for prostatectomy underwent MRI at 1.5 Tesla using the dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence (temporal resolution, 1.65 s) and a combined endorectal body phased array coil. Parametric maps were computed using a sequential 3-compartment model and the corresponding post-processing algorithms. A total of 41 areas of prostate cancer (15 low-grade, 26 high-grade cancers) in 32 patients were able to be correlated with the prostatectomy specimens and were included in the analysis.

RESULTS

Low-grade prostate cancers had a higher mean blood volume (1.76 % vs. 1.64 %, p = 0.039), longer MTT (6.39 s vs. 3.25 s, p < 0.001), and lower mean permeability (2.57 min (-1) vs. 3.86 min (-1), p = 0.011) than high-grade cancers. No statistically significant difference was found for perfusion (p = 0.069), interstitial volume (p = 0.849), extraction coefficient (p = 0.615), delay (p = 0.489), and dispersion (p = 0.306).

CONCLUSIONS

Blood volume, MTT, and permeability allow the differentiation of low-grade and high-grade prostate cancer. They may be used to detect cancer progression by MRI in patients managed by active surveillance.

摘要

目的

研究药代动力学磁共振成像参数“灌注、血容量、平均通过时间(MTT)、组织间隙容积、通透性、提取系数、延迟和弥散”是否能够区分低级别(Gleason评分≤6)和高级别(Gleason评分≥7)前列腺癌。

材料与方法

42例经活检证实患有前列腺癌(前列腺特异抗原2.7至31.4 ng/ml)且计划接受前列腺切除术的患者,使用动态对比增强反转预饱和双对比梯度回波序列(时间分辨率为1.65秒)和联合直肠内体部相控阵线圈,在1.5特斯拉场强下进行磁共振成像检查。使用序贯三室模型和相应的后处理算法计算参数图。32例患者中总共41个前列腺癌区域(15个低级别癌、26个高级别癌)能够与前列腺切除标本相关联,并纳入分析。

结果

低级别前列腺癌的平均血容量较高(1.76%对1.64%,p = 0.039),MTT较长(6.39秒对3.25秒,p < 0.001),平均通透性较低(2.57分钟⁻¹对3.86分钟⁻¹,p = 0.011),高于高级别癌。在灌注(p = 0.069)、组织间隙容积(p = 0.849)、提取系数(p = 0.615)、延迟(p = 0.489)和弥散(p = 0.306)方面未发现统计学显著差异。

结论

血容量、MTT和通透性能够区分低级别和高级别前列腺癌。它们可用于在接受主动监测的患者中通过磁共振成像检测癌症进展。

相似文献

1
[Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].[前列腺的药代动力学磁共振成像:区分低级别和高级别前列腺癌的参数]
Rofo. 2009 Jun;181(6):536-42. doi: 10.1055/s-0028-1109168. Epub 2009 Apr 7.
2
Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.使用动态对比增强反转准备双对比梯度回波序列通过定量灌注分析评估正常前列腺组织、慢性前列腺炎和前列腺癌。
Invest Radiol. 2008 Jul;43(7):481-7. doi: 10.1097/RLI.0b013e31816b2f63.
3
MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.前列腺癌患者外照射强度调制放疗前后的 MRI:使用动态对比增强反转准备双对比梯度回波序列监测放射性组织变化的可行性。
Radiother Oncol. 2009 Nov;93(2):241-5. doi: 10.1016/j.radonc.2009.08.016. Epub 2009 Sep 10.
4
Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.使用反转准备梯度回波序列和血池造影剂时,水交换对基于MRI测定相对血容量的影响。
Magn Reson Imaging. 2009 Apr;27(3):360-9. doi: 10.1016/j.mri.2008.07.005. Epub 2008 Sep 2.
5
Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.在动物模型中前列腺癌与正常前列腺组织的鉴别:传统MRI和动态对比增强MRI
Rofo. 2005 Jul;177(7):935-9. doi: 10.1055/s-2005-858295.
6
Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.从正常前列腺组织中鉴别前列腺癌:药代动力学 MRI 与组织学评估中的热点作用。
AJR Am J Roentgenol. 2010 Mar;194(3):675-81. doi: 10.2214/AJR.09.3233.
7
Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.基于动态对比增强磁共振成像的洗入率:对前列腺癌检测和定位的效用
J Magn Reson Imaging. 2005 Nov;22(5):639-46. doi: 10.1002/jmri.20431.
8
Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.扩散加权成像和动态对比增强磁共振成像在前列腺移行区癌诊断中的应用价值
Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959.
9
Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.前列腺磁共振成像:利用药代动力学容积和血流参数进行组织特征分析及其与组织学参数的相关性
Radiology. 2009 Jul;252(1):101-8. doi: 10.1148/radiol.2521081400.
10
Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.前列腺动态对比增强磁共振成像分析:快速交换极限与快速交换方案药代动力学模型在鉴别恶性组织与正常组织中的比较
Invest Radiol. 2009 Sep;44(9):577-84. doi: 10.1097/RLI.0b013e3181b4c1fe.

引用本文的文献

1
Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.关于局部前列腺癌多参数磁共振成像的国际泌尿外科学会-国际泌尿病理学会咨询的最新情况。
World J Urol. 2019 Mar;37(3):429-436. doi: 10.1007/s00345-018-2395-3. Epub 2018 Jul 12.
2
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa).中国前列腺癌(PCa)患者体细胞 EGFR 和 KRAS 基因突变状态。
Virchows Arch. 2014 May;464(5):575-81. doi: 10.1007/s00428-014-1566-x. Epub 2014 Mar 5.
3
[Prostate cancer].
[前列腺癌]
Radiologe. 2014 May;54(5):491-506; quiz 507. doi: 10.1007/s00117-013-2608-0.
4
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.原发性前列腺癌中的表皮生长因子受体 (EGFR) 突变分析、基因表达谱分析和 EGFR 蛋白表达。
BMC Cancer. 2011 Jan 25;11:31. doi: 10.1186/1471-2407-11-31.
5
Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.动态对比增强磁共振成像与前列腺癌的药代动力学模型。
Eur Radiol. 2011 Mar;21(3):616-26. doi: 10.1007/s00330-010-2037-7. Epub 2010 Dec 24.
6
Active surveillance for favorable-risk prostate cancer: a short review.低危前列腺癌的主动监测:简要综述
Korean J Urol. 2010 Oct;51(10):665-70. doi: 10.4111/kju.2010.51.10.665. Epub 2010 Oct 21.
7
MRI for men undergoing active surveillance or with rising PSA and negative biopsies.对接受主动监测或 PSA 升高且前列腺活检阴性的男性进行 MRI 检查。
Nat Rev Urol. 2010 Oct;7(10):543-51. doi: 10.1038/nrurol.2010.143.